Author/Authors :
de Mello، Marco T?lio نويسنده Departamento de Psicobiologia, Universidade Federal de S?o Paulo, S?o Paulo/SP , , Narciso، Fernanda Veruska نويسنده Associaç?o Fundo de Incentivo a Pesquisa, S?o Paulo/SP , , Tufik، Sergio نويسنده Departamento de Psicobiologia, Universidade Federal de S?o Paulo, S?o Paulo/SP , , Paiva، Teresa نويسنده Institute of Molecular Medicine, Medical Faculty of Lisbon and Director, CENC?Sleep Medicine Center, Lisbon , , Spence، David Warren نويسنده 323 Brock Ave, Toronto, ON M6K 2M6 , , BaHammam، Ahmed S. نويسنده University Sleep Disorders Center, College of Medicine, King Saud University, Riyadh , , Verster، Joris C. نويسنده Division of Pharmacology, Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Universiteitsweg 99, Utrecht , , Pandi?Perumal، Seithikurippu R. نويسنده University Sleep Disorders Center, College of Medicine, King Saud University, Riyadh ,
Abstract :
Studies have shown that a large proportion of traffic accidents around
the world are related to inadequate or disordered sleep. Recent surveys
have linked driver fatigue to 16% to 20% of serious highway accidents
in the UK, Australia, and Brazil. Fatigue as a result of sleep disorders
(especially obstructive sleep apnea), excessive workload and lack of
physical and mental rest, have been shown to be major contributing
factors in motor vehicle accidents. A number of behavioral,
physiological, and psychometric tests are being used increasingly to
evaluate the impact of fatigue on driver performance. These include
the oculography, polysomnography, actigraphy, the maintenance of
wakefulness test, and others. Various strategies have been proposed
for preventing or reducing the impact of fatigue on motor vehicle
accidents. These have included: Educational programs emphasizing the
importance of restorative sleep and the need for drivers to recognize
the presence of fatigue symptoms, and to determine when to stop
to sleep; The use of exercise to increase alertness and to promote
restorative sleep; The use of substances or drugs to promote sleep or
alertness (i.e. caffeine, modafinil, melatonin and others), as well as
specific sleep disorders treatment; The use of CPAP therapy for
reducing excessive sleepiness among drivers who have been diagnosed
with obstructive sleep apnea. The evidence cited in this review justifies
the call for all efforts to be undertaken that may increase awareness
of inadequate sleep as a cause of traffic accidents. It is strongly
recommended that, for the purpose of promoting highway safety and
saving lives, all disorders that cause excessive sleepiness should be
investigated and monitored.